Independent experts would have given this story important context.
One potential harm is that this technique still misses some malignant lesions.
The actual cost implications of the new test are anything but clear based on this news release.
This story also missed an opportunity to point out other ways to reduce unneeded CT scans.
This story buoyantly reports on a finding that amyloid plaque can be reversed in mice but misses potential harms and an announcement about an aborted BACE1 trial in humans just a day earlier.
News releases about new diagnostic tests will be read by patients and their families and should strive to discuss the impact of early diagnosis, beyond the potential benefits for research.
The two major outcomes measured in this study (pain control and quality of life) were measured using questionnaires which are highly subjective and difficult to reproduce. There was no control or comparison group.
Far more original reporting was needed here.